Secondary Bone Cancer Statistics
Links shared publicly online about this topic
Trends in Bone Cancer - EmpowHER.com
empowher.com — “Read about some of the latest research and statistics relating to bone cancer.” View full resource at empowher.com
Most Recently Shared on March 23, 2011 at 11:00 pm By:
Trends in bone cancer - what is the most common age to get it & what are the most common treatments? http://ow.ly/4kU0e
Bone Metastases Treatment For Cancer Patients Has Positive Results | ThirdAge
thirdage.com — “Bone Metastases treated with Alpharadin has positive results for patients, studies find.” View full resource at thirdage.com
Most Recently Shared on November 1, 2010 at 11:40 pm By:
Bone Metastases Treatment For Cancer Patients Has Positive Results http://bit.ly/aMsG2r
Types of malignant bone cancer - by Nicole Evans M.D. - Helium
helium.com — “There are several types of malignant bone tumors. Secondary bone cancer that occurs when cancer from elsewhere in the body spreads to the bo..., Nicole Evans M.D.” View full resource at helium.com
Most Recently Shared on February 10, 2011 at 2:37 am By:
Nicole Evans M.D. Doctor, Medical Student, and Physician
The types of malignant bone #cancer http://9mp.com/bone-cancer
Treating Bone Loss in Breast Cancer Survivors
newswise.com — “Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. A new study has found that bone loss can be halted with a comprehensive regimen that includes both osteoporosis drugs and treatments that target secondary causes of bone loss.” View full resource at newswise.com
Most Recently Shared on September 15, 2009 at 7:02 am By:
Treating Bone Loss in Breast Cancer Survivors http://bit.ly/jnDTc
Treating bone loss in breast cancer survivors
physorg.com — “A key statistic that consumer groups and the media often use when compiling hospital report cards and national rankings can be misleading, researchers report in a new study.” View full resource at physorg.com
Most Recently Shared on September 15, 2009 at 11:15 am By:
Treating bone loss in breast cancer survivors http://bit.ly/A58gB
Published Results Show Denosumab Superior To Zometa(R) In Delaying Or Preventing Bone Complications In Patients With Advanced Breast Cancer
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa(R) (zoledronic acid) in delaying or preventing skeleta” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 4:05 pm By:
MNT Bones/Orthopedic Health News
Published Results Show Denosumab Superior To Zometa(R) In Delaying Or Preventing Bone Complications In Patients With A... http://mnt.to/3Mm2
Denosumab Demonstrated Superiority Over Zometa(R) In Pivotal Phase 3 Head-to-Head Trial In Prostate Cancer Patients With Bone Metastases
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced” View full resource at medicalnewstoday.com
Most Recently Shared on February 9, 2010 at 7:11 pm By:
MNT Clinical Trials Health News
Denosumab Demonstrated Superiority Over Zometa(R) In Pivotal Phase 3 Head-to-Head Trial In Prostate Cancer Patients Wi... http://mnt.to/3xnG
Treating Bone Loss In Breast Cancer Survivors: Cancer Drugs Aren't The Only Culprits
sciencedaily.com — “Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. A new study has found that bone loss can be halted with a comprehensive regimen that includes both osteoporosis drugs and treatments that target secondary causes of bone loss.” View full resource at sciencedaily.com
Most Recently Shared on September 21, 2009 at 9:53 pm By:
Treating Bone Loss In Breast Cancer Survivors: Cancer Drugs Aren't The Only Culprits http://ow.ly/15QbYG
Glasgow Company Launches New Vitamin D Superfood As Shocking Statistics Reveal 50% Of People Suffer From Vitamin D Deficiency
medicalnewstoday.com — “Health Secretary Nicola Sturgeon has announced a leaflet initiative in Scotland urging people to make sure they get enough vitamin D, among concern that people are not getting enough of the vitami” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2010 at 2:05 pm By:
MNT - Comp Medicine Health News
Glasgow Company Launches New Vitamin D Superfood As Shocking Statistics Reveal 50% Of People Suffer From Vitamin D Def... http://mnt.to/3Kck
Denosumab superior to Zometa in delaying/preventing bone complications in advanced breast cancer patients -- data published today in Journal of Clinical Oncology - Drugs.com MedNews
drugs.com — “Published RESULTS SHOW Denosumab SUPERIOR TO ZOMETA in DELAYING OR PREVENTING Bone COMPLICATIONS in Patients WITH BONE METASTASES FROM Advanced Breast Cancer Bo” View full resource at drugs.com
Most Recently Shared on November 9, 2010 at 5:16 pm By:
Drugs and Devices OW OW Health
Denosumab superior to Zometa in delaying/preventing bone complications in advanced breast cancer patients ... http://bit.ly/dDc0AX #drug
Phase 3 study of denosumab for the treatment of bone metastases associated with breast cancer - MPR
empr.com — “Amgen announced that its Phase 3 trial comparing denosumab to Zometa (zoledronic acid, from Novartis) in the treatment of bone metastases in patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.” View full resource at empr.com
Most Recently Shared on July 8, 2009 at 5:47 pm By:
MPR News: Phase 3 study of denosumab for the treatment of bone metastases associated with breast cancer.. http://tinyurl.com/n95msa
Denosumab superior to Zometa in preventing SREs in breast cancer patients with bone metastases: Study
news-medical.net — “Amgen today announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa® (zoledronic acid) in delaying or preventing skeletal-related events (SREs) in breast cancer patients with bone metastases. An SRE consists of any of the following: a pathologic fracture, the need for radiation or surgery to ameliorate bone pathology secondary to tumor growth, or spinal cord compression.” View full resource at news-medical.net
Most Recently Shared on November 9, 2010 at 7:51 am By:
Lung Cancer News: Denosumab superior to Zometa in preventing SREs in breast cancer patients with bone metastases... http://bit.ly/d7VhZd
Topline Results From Phase 3 Trial Of Sunitinib With Erlotinib In Advanced Non-Small Cell Lung Cancer (NSCLC)
medicalnewstoday.com — “Pfizer Inc. (NYSE :PFE) announced that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but n” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2010 at 1:00 pm By:
Topline Results From Phase 3 Trial Of Sunitinib With Erlotinib In Advanced Non-Small Cell Lung Cancer (NSCLC) http://mnt.to/3HLc #lungcancer
Ask Dr. Berenson: Updates on Myeloma Treatment and Bone Health (August 2011) - Patient Power
patientpower.info — “In this edition of our ongoing video series, Dr. James Berenson updates us on a wide range of myeloma treatment options, the research that is impacting treatment, and answers your questions. Additionally, Dr. Berenson covers the risk of secondary cancers that may be associated with myeloma drugs and the ongoing evolution in the treatment of bone health.” View full resource at patientpower.info
Most Recently Shared on August 18, 2011 at 7:08 pm By:
Updates on Myeloma Treatment and Bone Health with Dr. Berenson - Patient Power - http://t.co/YttWdLK #myeloma #bloodcancer
Sirolimus reduced skin cancer incidence in renal transplant recipients
endocrinetoday.com — “ASN Renal Week 2011 PHILADELPHIA — The use of sirolimus led to a statistically significant reduction in the number of skin cancers amon” View full resource at endocrinetoday.com
Most Recently Shared on November 22, 2011 at 4:24 pm By:
Investigational drug may help treat mineral, #bone disorder in CKD http://t.co/4cky6ZA6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
EmpowHER
EmpowHER is a dedicated place for women's health online
-
ThirdAge.com
A boomer's guide to a life of health, happiness, passion & purpose.
-
Nicole Evans M.D.
I'm a resident physician with a passion for Integrative Medicine. I love sharing info on health, disease & the art of medicine.
Advertisement
